The CIPN treatment landscape is poised for significant growth, primarily driven by increasing cancer prevalence and emerging targeted therapies. Key pharmaceutical companies, including WEX Pharmaceuticals, Laboratorios Dr. Esteve S.A., Main Line Health/Ananda Hemp, Inc., AlgoTx, Artelo Biosciences, and Asahi Kasei, among others, are spearheading transformative advancements to improve patient outcomes in this therapeutic area, according […]
